Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Viewpoints
Showing 9281 - 9288 of 11685 results
Factors the SEC Considers When Deciding Whether to Grant a Waiver to a Statutory Disqualification
March 20, 2015| Blog| Viewpoint
2015 Employment Law Issues Tournament: Second Round Results and Recaps
March 19, 2015| Blog| Viewpoint
Restrictive Covenants: The Employee Choice Doctrine Explained … Yet Again
March 19, 2015| Blog| Viewpoint
Understanding Post-AIA Power of Attorney Procedures
March 19, 2015| Blog| Viewpoint
Department of Energy Releases Wind Vision Report: Accelerating Growth Offers a Promising Future
March 19, 2015| Blog| Viewpoint
Court Denies Generic Drug Manufacturer's Motion to Dismiss Hatch-Waxman Patent Infringement Action on Jurisdiction Grounds
March 18, 2015| Blog| Viewpoint
ML Strategies Posts Weekly Health Care Update on March 16, 2015
March 18, 2015| Blog| Viewpoint
News & Press Releases
Mintz Expands Energy & Sustainability Practice with Projects & Infrastructure Member Luis F. Torres
January 27, 2025
Luis F. Torres has joined as a Member of Mintz’s Energy & Sustainability Practice in the firm’s Washington, DC and New York offices. An accomplished project finance lawyer, Luis’s practice focuses on the structuring, development, and financing of energy, transport, telecommunications, and other infrastructure projects in the United States, Latin America, and other jurisdictions around the globe.
Mintz represented Quorum Cyber Security, a platform company of Charlesbank Capital Partners, in its acquisition of Kivu Consulting, Inc., a global cybersecurity firm specializing in Incident Response.
Mintz Represents Granata Bio Corporation in Series A+ Funding Round
January 24, 2025
Mintz represented Granata Bio Corporation (Granata Bio), a biopharma company focused on invigorating the $3.6B global infertility medication market, in its $15M Series A+ funding round.